Torrent Pharmaceuticals, 500420, TORNTPHARM Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,16,230.63
64.50
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,18,128.63
0.82%
15.49

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.71
6.21
8.03

EBITDA CAGR (%)

10 Years
5 Years
3 Years

12.67
9.16
6.71

PAT CAGR (%)

10 Years
5 Years
3 Years

8.23
10.08
28.69

P:E (Median)

8 Years
5 Years
3 Years

44.04
53.68
60.42

P:BV (Average)

8 Years
5 Years
3 Years

8.02
9.46
10.43

EV:EBITDA (Average)

8 Years
5 Years
3 Years

20.33
22.70
24.33

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 48.94 59.39 77.66 93.3
P/E Ratio 65.89 54.29 41.52 34.56
Revenue 10562 11930 13462 15044
EBITDA 3368 3889 4512 5235
Net Income 1656 2007 2618 3157
ROA 11 15.3 18.8 20
P/Bk Ratio 15.92 13.71 10.95 8.97
ROE 25.38 27.1 29.95 30.14
FCFF 2475.46 2246.77 3014.21 3256.44
FCFF Yield 2.21 2 2.69 2.9

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 2,434.00 2,146.00 13.42% 2,438.00 2,121.00 14.95% 2,143.00 1,920.00 11.61% 2,123.00 1,914.00 10.92%
Expenses 1,513.00 1,410.00 7.30% 1,539.00 1,384.00 11.20% 1,427.00 1,342.00 6.33% 1,422.00 1,312.00 8.38%
EBITDA 921.00 736.00 25.14% 899.00 737.00 21.98% 716.00 578.00 23.88% 701.00 602.00 16.45%
EBIDTM 37.84% 34.30% 36.87% 34.75% 33.41% 30.10% 33.02% 31.45%
Other Income -7.00 15.00 - 21.00 11.00 90.91% 76.00 26.00 192.31% -11.00 16.00 -
Interest 54.00 77.00 -29.87% 64.00 90.00 -28.89% 67.00 94.00 -28.72% 69.00 91.00 -24.18%
Depreciation 190.00 192.00 -1.04% 189.00 183.00 3.28% 195.00 182.00 7.14% 191.00 185.00 3.24%
PBT 670.00 482.00 39.00% 667.00 475.00 40.42% 530.00 328.00 61.59% 430.00 342.00 25.73%
Tax 210.00 155.00 35.48% 198.00 152.00 30.26% 120.00 109.00 10.09% 133.00 108.00 23.15%
PAT 460.00 327.00 40.67% 469.00 323.00 45.20% 410.00 219.00 87.21% 297.00 234.00 26.92%
PATM 18.90% 15.24% 19.24% 15.23% 19.13% 11.41% 13.99% 12.23%
EPS 13.59 9.66 40.68% 13.86 9.54 45.28% 12.12 6.47 87.33% 8.78 6.91 27.06%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 2,889.00 2,660.00 8.61% 2,859.00 2,591.00 10.34% 2,745.00 2,491.00 10.20% 2,732.00 2,491.00 9.67%
Expenses 1,950.00 1,835.00 6.27% 1,955.00 1,800.00 8.61% 1,862.00 1,764.00 5.56% 1,863.00 1,767.00 5.43%
EBITDA 939.00 825.00 13.82% 904.00 791.00 14.29% 883.00 727.00 21.46% 869.00 724.00 20.03%
EBIDTM 32.50% 31.02% 31.62% 30.53% 32.17% 29.19% 31.81% 29.06%
Other Income -16.00 26.00 - 24.00 34.00 -29.41% 31.00 9.00 244.44% -33.00 -10.00 -
Interest 64.00 91.00 -29.67% 75.00 103.00 -27.18% 80.00 107.00 -25.23% 80.00 102.00 -21.57%
Depreciation 198.00 201.00 -1.49% 197.00 191.00 3.14% 203.00 196.00 3.57% 213.00 193.00 10.36%
PBT 661.00 559.00 18.25% 656.00 531.00 23.54% 631.00 433.00 45.73% 631.00 419.00 50.60%
Tax 208.00 173.00 20.23% 199.00 153.00 30.07% 182.00 146.00 24.66% 188.00 127.00 48.03%
PAT 453.00 386.00 17.36% 457.00 378.00 20.90% 449.00 287.00 56.45% 443.00 292.00 51.71%
PATM 15.68% 14.51% 15.98% 14.59% 16.36% 11.52% 16.22% 11.72%
EPS 13.38 11.40 17.37% 13.50 11.17 20.86% 13.27 8.48 56.49% 13.09 8.63 51.68%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 9,138.00 8,532.90 7,695.20 6,742.32 6,450.57 6,168.44 5,762.48 4,244.43 4,551.45 5,419.59 3,475.55 Net Sales Growth 12.80% 10.89% 14.13% 4.52% 4.57% 7.04% 35.77% -6.75% -16.02% 55.93% Cost Of Goods Sold 2,217.00 1,904.52 1,917.47 1,697.36 1,483.37 1,452.32 1,366.31 977.39 1,224.44 1,037.62 949.53 Gross Profit 6,921.00 6,628.38 5,777.73 5,044.96 4,967.20 4,716.12 4,396.17 3,267.04 3,327.01 4,381.97 2,526.02 GP Margin 75.74% 77.68% 75.08% 74.83% 77.00% 76.46% 76.29% 76.97% 73.10% 80.85% 72.68% Total Expenditure 5,901.00 5,643.73 5,230.04 4,641.60 4,258.84 4,251.45 4,149.45 3,337.05 3,424.30 2,778.67 2,640.36 Power & Fuel Cost - 143.43 153.21 140.00 122.04 126.70 131.49 117.86 107.17 91.17 96.57 % Of Sales - 1.68% 1.99% 2.08% 1.89% 2.05% 2.28% 2.78% 2.35% 1.68% 2.78% Employee Cost - 1,450.67 1,251.22 1,097.93 1,097.12 1,061.76 1,014.06 826.07 699.04 572.10 507.41 % Of Sales - 17.00% 16.26% 16.28% 17.01% 17.21% 17.60% 19.46% 15.36% 10.56% 14.60% Manufacturing Exp. - 534.71 518.96 525.94 467.64 510.53 511.80 424.29 483.38 353.59 339.26 % Of Sales - 6.27% 6.74% 7.80% 7.25% 8.28% 8.88% 10.00% 10.62% 6.52% 9.76% General & Admin Exp. - 636.24 543.33 445.93 432.42 428.65 528.34 492.53 397.46 324.98 345.58 % Of Sales - 7.46% 7.06% 6.61% 6.70% 6.95% 9.17% 11.60% 8.73% 6.00% 9.94% Selling & Distn. Exp. - 886.54 788.92 673.65 595.84 596.66 539.39 453.50 388.99 366.53 391.17 % Of Sales - 10.39% 10.25% 9.99% 9.24% 9.67% 9.36% 10.68% 8.55% 6.76% 11.25% Miscellaneous Exp. - 87.62 56.93 60.79 60.41 74.83 58.06 45.41 123.82 32.68 391.17 % Of Sales - 1.03% 0.74% 0.90% 0.94% 1.21% 1.01% 1.07% 2.72% 0.60% 0.31% EBITDA 3,237.00 2,889.17 2,465.16 2,100.72 2,191.73 1,916.99 1,613.03 907.38 1,127.15 2,640.92 835.19 EBITDA Margin 35.42% 33.86% 32.04% 31.16% 33.98% 31.08% 27.99% 21.38% 24.76% 48.73% 24.03% Other Income 79.00 91.49 81.88 204.21 118.34 236.93 381.96 332.31 299.60 293.49 313.83 Interest 254.00 303.04 297.68 236.29 334.12 430.49 480.97 293.68 202.38 179.83 172.72 Depreciation 765.00 761.05 672.34 602.43 609.84 606.66 578.90 383.88 269.36 213.41 180.22 PBT 2,297.00 1,916.57 1,577.02 1,466.21 1,366.11 1,116.77 935.12 562.13 955.01 2,541.17 796.08 Tax 661.00 559.49 525.63 474.76 228.26 178.26 189.70 80.09 100.79 605.36 172.90 Tax Rate 28.78% 29.19% 33.33% 32.38% 16.71% 15.96% 20.29% 14.25% 10.55% 25.78% 21.72% PAT 1,636.00 1,357.08 1,051.39 991.45 1,137.85 938.51 745.42 482.04 854.22 1,742.99 623.18 PAT before Minority Interest 1,636.00 1,357.08 1,051.39 991.45 1,137.85 938.51 745.42 482.04 854.22 1,742.99 623.18 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 17.90% 15.90% 13.66% 14.70% 17.64% 15.21% 12.94% 11.36% 18.77% 32.16% 17.93% PAT Growth 48.32% 29.07% 6.05% -12.87% 21.24% 25.90% 54.64% -43.57% -50.99% 179.69% EPS 48.35 40.10 31.07 29.30 33.62 27.73 22.03 14.24 25.24 51.51 18.42

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 11,225.00 10,727.84 9,620.15 8,508.04 8,004.57 7,939.31 7,672.80 5,949.83 5,815.69 6,666.85 4,653.45 Net Sales Growth 9.69% 11.51% 13.07% 6.29% 0.82% 3.47% 28.96% 2.31% -12.77% 43.27% Cost Of Goods Sold 2,748.00 2,458.95 2,513.20 2,230.75 1,960.12 1,981.79 2,041.26 1,535.17 1,629.66 1,432.13 1,280.96 Gross Profit 8,477.00 8,268.89 7,106.95 6,277.29 6,044.45 5,957.52 5,631.54 4,414.66 4,186.03 5,234.72 3,372.49 GP Margin 75.52% 77.08% 73.88% 73.78% 75.51% 75.04% 73.40% 74.20% 71.98% 78.52% 72.47% Total Expenditure 7,630.00 7,364.25 6,796.18 6,076.77 5,524.49 5,768.95 5,696.31 4,600.58 4,438.42 3,937.05 3,633.29 Power & Fuel Cost - 145.20 155.28 144.19 122.94 128.19 132.46 118.77 107.98 92.59 97.41 % Of Sales - 1.35% 1.61% 1.69% 1.54% 1.61% 1.73% 2.00% 1.86% 1.39% 2.09% Employee Cost - 1,984.40 1,677.69 1,526.45 1,439.62 1,429.04 1,403.79 1,135.25 993.41 842.35 841.81 % Of Sales - 18.50% 17.44% 17.94% 17.98% 18.00% 18.30% 19.08% 17.08% 12.63% 18.09% Manufacturing Exp. - 570.58 570.79 591.13 550.92 544.11 558.84 457.58 502.16 353.45 345.98 % Of Sales - 5.32% 5.93% 6.95% 6.88% 6.85% 7.28% 7.69% 8.63% 5.30% 7.43% General & Admin Exp. - 980.72 775.30 637.65 633.48 801.98 763.90 677.71 578.05 637.92 463.28 % Of Sales - 9.14% 8.06% 7.49% 7.91% 10.10% 9.96% 11.39% 9.94% 9.57% 9.96% Selling & Distn. Exp. - 1,129.68 1,026.99 884.91 742.63 807.39 738.03 641.30 567.70 547.05 574.40 % Of Sales - 10.53% 10.68% 10.40% 9.28% 10.17% 9.62% 10.78% 9.76% 8.21% 12.34% Miscellaneous Exp. - 94.72 76.93 61.69 74.78 76.45 58.03 34.80 59.46 31.56 574.40 % Of Sales - 0.88% 0.80% 0.73% 0.93% 0.96% 0.76% 0.58% 1.02% 0.47% 0.63% EBITDA 3,595.00 3,363.59 2,823.97 2,431.27 2,480.08 2,170.36 1,976.49 1,349.25 1,377.27 2,729.80 1,020.16 EBITDA Margin 32.03% 31.35% 29.35% 28.58% 30.98% 27.34% 25.76% 22.68% 23.68% 40.95% 21.92% Other Income 6.00 61.97 63.22 196.56 56.91 121.30 63.62 298.84 223.30 228.80 285.55 Interest 299.00 353.56 333.44 255.06 352.94 450.71 503.75 308.48 205.56 183.98 175.16 Depreciation 811.00 808.27 706.59 662.16 657.79 654.38 617.69 408.60 306.92 237.55 190.74 PBT 2,579.00 2,263.73 1,847.16 1,710.61 1,526.26 1,186.57 918.67 931.01 1,088.09 2,537.07 939.81 Tax 777.00 695.73 601.93 448.73 274.38 161.85 125.35 252.87 154.51 610.17 188.84 Tax Rate 30.13% 29.58% 32.59% 36.60% 17.98% 13.64% 22.32% 27.16% 14.20% 26.04% 20.09% PAT 1,802.00 1,656.38 1,245.23 777.18 1,251.88 1,024.72 436.28 678.11 933.55 1,733.24 750.94 PAT before Minority Interest 1,802.00 1,656.38 1,245.23 777.18 1,251.88 1,024.72 436.31 678.14 933.58 1,733.27 750.97 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 -0.03 -0.03 -0.03 -0.03 -0.03 PAT Margin 16.05% 15.44% 12.94% 9.13% 15.64% 12.91% 5.69% 11.40% 16.05% 26.00% 16.14% PAT Growth 34.18% 33.02% 60.22% -37.92% 22.17% 134.88% -35.66% -27.36% -46.14% 130.81% EPS 53.25 48.95 36.80 22.97 36.99 30.28 12.89 20.04 27.59 51.22 22.19

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 6,828.76 6,455.96 6,345.42 6,030.10 5,120.97 5,015.27 4,556.49 4,453.71 3,707.31 2,705.59 Share Capital 169.23 169.23 84.62 84.62 84.62 84.62 84.62 84.62 84.62 84.62 Total Reserves 6,659.53 6,286.73 6,260.80 5,945.48 5,036.35 4,930.65 4,471.87 4,369.09 3,622.69 2,620.97 Non-Current Liabilities 2,559.23 3,006.82 2,383.78 3,116.81 3,308.26 3,924.18 4,275.21 2,442.69 2,079.28 2,478.12 Secured Loans 1,603.78 2,331.78 1,971.60 2,941.07 3,138.43 3,736.88 4,105.31 2,197.48 1,773.65 2,171.60 Unsecured Loans 0.00 0.00 0.00 0.00 1.56 3.11 6.15 11.26 10.62 13.62 Long Term Provisions 282.15 244.54 210.83 193.93 176.72 163.77 149.10 126.34 114.69 97.12 Current Liabilities 2,988.60 3,409.15 2,423.36 2,585.80 3,387.48 3,087.82 2,987.55 1,154.51 1,501.95 1,313.20 Trade Payables 759.76 610.63 624.21 648.05 682.07 582.33 775.72 547.95 665.17 630.23 Other Current Liabilities 827.90 1,450.12 1,278.84 1,420.54 1,822.33 1,694.82 1,091.57 551.16 789.83 413.71 Short Term Borrowings 1,200.00 1,197.77 399.97 410.38 789.31 726.60 1,040.20 0.00 0.00 100.00 Short Term Provisions 200.94 150.63 120.34 106.83 93.77 84.07 80.06 55.40 46.95 169.26 Total Liabilities 12,376.59 12,871.93 11,152.56 11,732.71 11,816.71 12,027.27 11,819.25 8,050.91 7,288.54 6,496.91 Net Block 7,985.92 7,971.85 6,251.25 6,741.24 7,197.50 7,425.15 7,428.53 3,523.49 2,681.39 2,763.50 Gross Block 12,999.81 12,366.86 10,002.35 9,952.74 9,805.61 9,465.64 8,905.10 4,634.19 3,531.56 3,416.05 Accumulated Depreciation 5,013.89 4,395.01 3,751.10 3,211.50 2,608.11 2,040.49 1,476.57 1,110.70 850.17 652.55 Non Current Assets 8,635.53 8,944.85 7,092.51 7,590.83 7,997.45 8,278.32 8,180.11 4,505.33 4,150.74 3,777.96 Capital Work in Progress 226.23 697.93 567.50 588.11 536.41 497.58 447.38 473.07 983.69 627.78 Non Current Investment 322.27 205.12 183.66 174.87 134.87 134.87 149.83 148.41 153.91 150.35 Long Term Loans & Adv. 95.24 68.42 65.30 75.61 100.91 93.35 93.32 237.96 246.50 186.05 Other Non Current Assets 5.87 1.53 24.80 11.00 27.76 127.37 61.05 122.40 85.25 50.28 Current Assets 3,741.06 3,927.08 3,933.40 4,141.88 3,819.26 3,748.95 3,639.14 3,545.58 3,137.80 2,718.95 Current Investments 141.04 156.09 183.98 139.05 0.02 351.35 475.22 787.43 764.24 283.48 Inventories 1,565.59 1,602.23 1,797.11 1,911.74 1,507.76 1,358.30 1,299.40 1,032.29 970.13 781.15 Sundry Debtors 1,571.94 1,729.44 1,541.35 1,544.26 1,508.94 1,356.01 1,108.04 1,018.47 911.50 1,181.32 Cash & Bank 108.76 147.61 69.46 66.42 390.95 237.84 57.09 78.22 82.37 69.68 Other Current Assets 353.73 156.52 232.90 439.17 411.59 445.45 699.39 629.17 409.56 403.32 Short Term Loans & Adv. 122.49 135.19 108.60 41.24 62.74 86.19 182.76 110.06 119.86 103.41 Net Current Assets 752.46 517.93 1,510.04 1,556.08 431.78 661.13 651.59 2,391.07 1,635.85 1,405.75 Total Assets 12,376.59 12,871.93 11,025.91 11,732.71 11,816.71 12,027.27 11,819.25 8,050.91 7,288.54 6,496.91

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 6,856.15 6,198.07 5,952.95 5,837.17 4,823.22 4,724.35 4,622.19 4,350.13 3,494.10 2,490.56 Share Capital 169.23 169.23 84.62 84.62 84.62 84.62 84.62 84.62 84.62 84.62 Total Reserves 6,686.92 6,028.84 5,868.33 5,752.55 4,738.60 4,639.73 4,537.57 4,265.51 3,409.48 2,405.94 Non-Current Liabilities 2,224.05 2,822.81 2,238.15 2,924.20 3,299.15 3,861.40 4,142.42 2,303.33 1,994.65 2,504.92 Secured Loans 1,603.78 2,496.22 2,123.22 2,941.07 3,302.29 3,909.81 4,105.31 2,229.57 1,839.46 2,171.60 Unsecured Loans 0.00 0.00 0.00 0.00 1.56 3.11 6.15 11.26 10.62 13.62 Long Term Provisions 444.69 393.06 368.74 369.62 338.34 288.52 286.66 263.04 246.36 207.49 Current Liabilities 5,425.25 5,447.30 4,415.09 4,891.62 5,454.16 5,165.32 5,202.17 2,738.26 3,285.48 2,823.75 Trade Payables 2,089.32 1,678.80 1,674.44 2,066.81 2,048.81 2,096.74 2,048.24 1,749.32 2,260.22 1,827.72 Other Current Liabilities 1,130.15 1,578.41 1,365.10 1,635.36 1,860.80 1,641.26 1,151.68 687.14 822.28 446.15 Short Term Borrowings 1,637.71 1,765.07 923.04 704.40 1,090.85 934.11 1,625.60 0.00 3.32 319.07 Short Term Provisions 568.07 425.02 452.51 485.05 453.70 493.21 376.65 301.80 199.66 230.81 Total Liabilities 14,505.45 14,468.18 12,606.19 13,652.99 13,576.53 13,751.07 13,967.30 9,392.21 8,774.69 7,819.66 Net Block 8,138.11 8,121.45 6,422.65 7,064.63 7,533.12 7,747.71 7,854.68 3,688.44 2,859.08 2,832.66 Gross Block 13,484.57 12,811.62 10,728.19 10,511.53 10,334.13 9,935.43 9,449.48 4,909.80 3,793.53 3,542.93 Accumulated Depreciation 5,346.46 4,690.17 4,305.54 3,446.90 2,801.01 2,187.72 1,594.80 1,221.36 934.45 710.27 Non Current Assets 8,893.97 9,139.00 7,311.54 8,129.77 8,595.61 8,713.53 8,704.89 4,512.74 4,085.66 3,768.25 Capital Work in Progress 360.51 765.40 629.82 889.38 711.93 617.12 646.94 519.49 1,041.58 678.33 Non Current Investment 31.80 42.70 42.33 42.09 2.09 2.09 0.09 0.09 0.09 0.06 Long Term Loans & Adv. 349.34 181.04 166.55 96.84 222.19 150.58 130.96 182.32 99.66 206.92 Other Non Current Assets 14.21 28.41 50.19 36.83 126.28 196.03 72.22 122.40 85.25 50.28 Current Assets 5,611.48 5,313.72 5,164.99 5,523.22 4,980.92 5,037.54 5,262.41 4,879.47 4,689.03 4,051.41 Current Investments 141.04 156.09 183.98 139.05 0.02 351.35 492.27 803.55 779.59 297.59 Inventories 2,279.07 2,229.64 2,462.32 2,681.20 2,148.22 1,935.15 1,966.30 1,559.15 1,357.98 1,067.17 Sundry Debtors 1,844.30 1,943.82 1,632.48 1,523.37 1,649.34 1,435.71 1,253.45 950.89 1,445.09 1,587.26 Cash & Bank 839.04 571.46 403.41 603.50 666.65 816.04 867.23 893.72 647.03 567.36 Other Current Assets 508.03 246.89 331.62 512.69 516.69 499.29 683.16 672.16 459.34 532.03 Short Term Loans & Adv. 180.04 165.82 151.18 63.41 73.48 93.46 95.39 82.62 90.18 109.09 Net Current Assets 186.23 -133.58 749.90 631.60 -473.24 -127.78 60.24 2,141.21 1,403.55 1,227.66 Total Assets 14,505.45 14,452.72 12,476.53 13,652.99 13,576.53 13,751.07 13,967.30 9,392.21 8,774.69 7,819.66

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 2,893.10 2,265.41 2,140.10 1,572.89 1,579.90 1,231.83 929.14 679.38 2,403.00 1,065.16 PBT 1,916.57 1,577.02 1,466.21 1,366.11 1,116.77 935.12 562.13 955.01 2,348.35 796.08 Adjustment 957.61 990.49 827.91 884.80 857.08 820.78 622.51 369.49 480.67 316.60 Changes in Working Capital 343.60 -29.64 86.25 -468.12 -187.25 -315.89 -123.22 -389.94 63.75 -13.74 Cash after chg. in Working capital 3,217.78 2,537.87 2,380.37 1,782.79 1,786.60 1,440.01 1,061.42 934.56 2,892.77 1,098.94 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -324.68 -272.46 -240.27 -209.90 -206.70 -208.18 -132.28 -255.18 -489.77 -33.78 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -296.07 -2,384.07 -159.70 -316.28 269.43 -373.33 -4,206.99 -532.60 -586.20 -2,098.70 Net Fixed Assets -161.25 -2,494.94 -29.00 -198.83 -378.80 -610.74 -4,245.22 -592.01 -471.42 -2,266.57 Net Investments -102.10 6.43 -53.72 -179.03 351.33 138.83 310.79 -17.69 -484.32 -111.97 Others -32.72 104.44 -76.98 61.58 296.90 98.58 -272.56 77.10 369.54 279.84 Cash from Financing Activity -2,577.57 80.74 -1,977.27 -1,581.20 -1,555.48 -927.58 2,928.72 -131.25 -1,325.82 995.73 Net Cash Inflow / Outflow 19.46 -37.92 3.13 -324.59 293.85 -69.08 -349.13 15.53 490.98 -37.81 Opening Cash & Equivalents 85.40 65.00 61.87 386.46 92.61 512.99 862.12 846.59 353.83 390.97 Closing Cash & Equivalent 104.86 85.40 65.00 61.87 386.46 443.91 512.99 862.12 846.59 353.16

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 3,266.08 2,368.13 1,802.99 2,005.35 1,392.91 1,798.08 894.15 1,008.84 2,742.12 810.20 PBT 2,352.11 1,847.16 1,225.91 1,526.26 1,186.57 561.66 931.01 1,088.09 2,343.44 939.81 Adjustment 993.99 937.24 1,349.95 992.84 876.21 1,418.19 606.92 430.27 552.44 337.96 Changes in Working Capital 418.08 -18.20 -351.85 -338.25 -385.83 99.39 -360.16 -125.21 423.58 -409.38 Cash after chg. in Working capital 3,764.18 2,766.20 2,224.01 2,180.85 1,676.95 2,079.24 1,177.77 1,393.15 3,319.46 868.39 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -498.10 -398.07 -421.02 -175.50 -284.04 -281.16 -283.62 -384.31 -577.34 -58.19 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -167.90 -2,415.31 -196.63 -449.42 198.61 -241.28 -4,706.95 -786.91 -837.85 -2,162.30 Net Fixed Assets -161.25 -2,494.94 -29.00 -198.83 -378.80 -610.74 -4,245.22 -592.01 -471.42 -2,266.57 Net Investments -102.10 6.43 -53.72 -179.03 351.33 138.83 310.79 -17.69 -484.32 -111.97 Others 95.45 73.20 -113.91 -71.56 226.08 230.63 -772.52 -177.21 117.89 216.24 Cash from Financing Activity -2,779.64 77.36 -1,781.05 -1,650.79 -1,549.04 -1,314.45 3,417.39 -192.91 -1,435.15 1,212.25 Net Cash Inflow / Outflow 318.54 30.18 -174.69 -94.86 42.48 242.35 -395.41 29.02 469.12 -139.85 Opening Cash & Equivalents 508.53 398.40 572.56 661.82 588.76 702.04 1,067.57 1,049.86 612.38 955.05 Closing Cash & Equivalent 835.14 508.53 398.40 572.56 661.82 940.06 702.04 1,067.57 1,049.86 864.95

Financial Ratios

Consolidated /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 201.76 190.75 187.47 178.15 302.59 296.34 269.23 263.16 219.06 159.87 ROA 10.75% 8.75% 8.66% 9.66% 7.87% 6.25% 4.85% 11.14% 25.29% 11.51% ROE 20.43% 16.43% 16.02% 20.41% 18.52% 15.58% 10.70% 20.93% 54.36% 24.95% ROCE 20.96% 18.10% 16.94% 16.30% 14.68% 13.46% 9.89% 18.01% 45.21% 22.40% Fixed Asset Turnover 0.69 0.70 0.69 0.66 0.65 0.63 0.64 1.12 1.57 1.47 Receivable days 69.19 76.09 82.04 85.05 83.57 77.19 90.16 76.69 70.22 130.91 Inventory Days 66.39 79.08 98.61 95.25 83.60 83.26 98.86 79.57 58.76 77.31 Payable days 131.32 117.53 136.79 163.65 52.42 59.32 72.18 69.01 88.12 80.19 Cash Conversion Cycle 4.26 37.63 43.85 16.66 114.75 101.13 116.84 87.25 40.85 128.03 Total Debt/Equity 0.49 0.71 0.53 0.73 1.04 1.12 1.28 0.55 0.61 0.93 Interest Cover 7.32 6.30 7.21 5.09 3.59 2.94 2.91 5.72 14.06 5.61

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 202.57 183.13 175.87 172.45 284.99 279.15 273.11 257.04 206.46 147.16 ROA 11.43% 9.20% 5.92% 9.20% 7.50% 3.15% 5.81% 10.28% 20.89% 11.71% ROE 25.38% 20.50% 13.18% 23.49% 21.47% 9.34% 15.12% 23.80% 57.92% 34.19% ROCE 24.28% 20.32% 14.35% 17.62% 15.28% 9.75% 13.81% 20.36% 45.63% 26.98% Fixed Asset Turnover 1.27 1.39 1.43 1.43 1.48 1.50 1.57 1.35 1.82 1.88 Receivable days 41.38 39.99 37.86 38.92 37.65 33.78 35.74 74.66 82.76 105.19 Inventory Days 49.26 52.47 61.71 59.24 49.84 49.01 57.16 90.90 66.19 81.17 Payable days 279.66 243.50 306.08 383.19 133.47 139.05 150.99 171.27 204.35 176.11 Cash Conversion Cycle -189.03 -151.04 -206.50 -285.04 -45.98 -56.26 -58.09 -5.72 -55.41 10.25 Total Debt/Equity 0.57 0.85 0.68 0.83 1.21 1.28 1.40 0.58 0.67 1.10 Interest Cover 7.65 6.54 5.81 5.32 3.63 2.11 4.02 6.29 13.74 6.37

Top Investors:

nps trust

investor education and protection fund (iepf)

Annual Reports:

News Update:

Torrent Pharma enters into agreement with Boehringer Ingelheim to acquire 3 anti-diabetes brands
5th Dec 2024, 11:12 AM

Torrent has been marketing these brands since 2022 as part of an existing co-marketing agreement with Boehringer Ingelheim India
Read More
Torrent Pharma - Quarterly Results
25th Oct 2024, 17:18 PM

Read More
Torrent Pharmaceuticals incorporates Wholly owned subsidiary in Chile
27th Sep 2024, 09:47 AM

Torrent Pharma Chile is incorporated with the object of providing business support to the company in the relevant jurisdiction
Read More
Torrent Pharmaceuticals raises Rs 200 crore through Commercial Papers
21st Sep 2024, 14:27 PM

The company has issued CPs at interest rate of 7.32% per annum
Read More

Torrent Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Global

BSE: 500420 | NSE: TORNTPHARM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Torrent Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Global

BSE: 500420 | NSE: TORNTPHARM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: